The U.S. Must Take Action on China's National Security–Related Life Sciences Programs
While the U.S. intelligence community toils to identify the exact origins of the SARS-COV2 (COVID-19) virus in the People’s Republic of China (PRC), there are additional reasons to be concerned about Beijing’s work in the life sciences, especially biotechnology. Indeed, the U.S. State Department and the Department of Defense (DOD) have publicly noted their unease with the PRC’s dual-use research and development (R&D) in biotechnology that may have offensive military purposes.
Source: heritage.org
